1-20 of 35
Authors: Margaret Johnson
Journal Article
INNV-31. THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii175, https://doi.org/10.1093/neuonc/noae165.0693
Published: 11 November 2024
Journal Article
CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii84, https://doi.org/10.1093/neuonc/noae165.0335
Published: 11 November 2024
Journal Article
CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS) Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii65, https://doi.org/10.1093/neuonc/noac209.255
Published: 14 November 2022
Journal Article
CTIM-24. NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii65, https://doi.org/10.1093/neuonc/noac209.256
Published: 14 November 2022
Journal Article
NCOG-43. A RETROSPECTIVE ANALYSIS OF THE IMPACT OF THE COVID-19 INFECTION ON NEURO-ONCOLOGY CARE AND PATIENT OUTCOMES: A TWO-SITE STUDY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii206–vii207, https://doi.org/10.1093/neuonc/noac209.794
Published: 14 November 2022
Journal Article
TMIC-15. AGE-RELATED MARKERS FOR SENESCENCE INCREASE IN THE OLDER ADULT EXTRATUMORAL MOUSE BRAIN DUE TO GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii274, https://doi.org/10.1093/neuonc/noac209.1059
Published: 14 November 2022
Journal Article
QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/TEMOZOLOMIDE Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii242, https://doi.org/10.1093/neuonc/noac209.935
Published: 14 November 2022
Journal Article
BIOM-43. THE GENOMIC, TRANSCRIPTOMIC, AND EPIGENOMIC LANDSCAPE OF ISOCITRATE DEHYDROGENASE WILD TYPE GLIOBLASTOMA ACROSS THE AGE CONTINUUM Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii13–vii14, https://doi.org/10.1093/neuonc/noac209.053
Published: 14 November 2022
Journal Article
INNV-31. NEURO-ONCOLOGY OUTPATIENT SATISFACTION IS MAINTAINED IN THE ERA OF COVID-19 TELEMEDICINE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi112, https://doi.org/10.1093/neuonc/noab196.442
Published: 12 November 2021
Journal Article
QOLP-28. COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND A NATIONALLY-REPRESENTATIVE U.S. SAMPLE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi189, https://doi.org/10.1093/neuonc/noab196.748
Published: 12 November 2021
Journal Article
QOLP-10. A LONGITUDINAL OBSERVATIONAL STUDY OF EXERCISE BEHAVIOR IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR-TREATING FIELDS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi184–vi185, https://doi.org/10.1093/neuonc/noab196.731
Published: 12 November 2021
Journal Article
CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi51, https://doi.org/10.1093/neuonc/noab196.202
Published: 12 November 2021
Journal Article
INNV-20. RADIOGRAPHIC RESPONSE AND SEIZURE CONTROL IN IDH1 MUTANT GLIOMA PATIENTS USING IVOSIDENIB Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi109, https://doi.org/10.1093/neuonc/noab196.431
Published: 12 November 2021
Journal Article
EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL Open Access
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i46, https://doi.org/10.1093/neuonc/noab090.187
Published: 01 June 2021
Journal Article
CTIM-23. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG) Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii38, https://doi.org/10.1093/neuonc/noaa215.157
Published: 09 November 2020
Journal Article
NCOG-23. PATTERNS OF DISTRESS IN OLDER PATIENTS WITH GLIOBLASTOMA: A FOLLOW-UP TO A SINGLE INSTITUTION CROSS-SECTIONAL STUDY OF DISTRESS IN PRIMARY BRAIN TUMOR PATIENTS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii134, https://doi.org/10.1093/neuonc/noaa215.561
Published: 09 November 2020
Journal Article
QOLP-20. A FEASIBILITY STUDY UTILIZING MINDFULNESS MEDITATION DURING CONCOMITANT CHEMORADIATION IN MALIGNANT GLIOMA PATIENTS: HEALTH-REPORTED QUALITY OF LIFE (HRQOL) RESULTS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii179, https://doi.org/10.1093/neuonc/noaa215.745
Published: 09 November 2020
Journal Article
QOLP-05. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii175, https://doi.org/10.1093/neuonc/noaa215.730
Published: 09 November 2020
Journal Article
COVD-25. THE PARADOXICAL EFFECTS OF COVID-19 ON CANCER CARE IN THE NEURO-ONCOLOGY SETTING Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii26, https://doi.org/10.1093/neuonc/noaa215.106
Published: 09 November 2020
Journal Article
INNV-11. GLIOBLASTOMA IN THE OLDER PERSON – HOW DO WE DECIDE ON TREATMENT? Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii118, https://doi.org/10.1093/neuonc/noaa215.494
Published: 09 November 2020
